One element of Pharmaceutical and Healthcare companies striving to adjust their business model and maintain their competitiveness, is an increasing trend to outsourcing. In such circumstances the quality of the support provided is critically important. This presents an opportunity for consultancy companies like Regulis, who have a high quality, focused, cost effective approach to the provision of their services and expertise.
Regulis recently won the TOPRA* Award for Support that was presented to Kim Wharton MD and founder of Regulis by Professor Trevor Jones, CBE, former Director General of the Association of the British Pharmaceutical Industry (ABPI) and member of the eminent judging panel.
Professor Jones commented “The nomination for Regulis said that they went beyond the call of duty when working with markets with very different time zones. Regulis carried out efficient due diligence and after successful acquisition of the product from a leading pharmaceutical company, efficiently transferred product licences in a number of EU and Asian markets, US and Australia. Regulis demonstrated a very high level of commercial awareness and production scheduling to ensure product was always available on time.” Professor Jones added “Regulis clearly punch above their weight. The level of professionalism and quality of service stands them and their clients in good stead in the future.”
Kim Wharton, MD of Regulis commented “It is great to receive this award in the year of our 10th anniversary. It provides direct feedback to us from our clients that we are doing the right things – things we want to continue and build on over the next few years as we expand the services to our clients.
*TOPRA is The Organisation for Professionals in Regulatory Affairs.